SFX by Ex Libris Inc.

Title:	Cancer: A tumour gene's fatal flaws
Source:	Nature [0028-0836] Downward, J yr:2009

Basic

Full text

Full text available via Nature

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Min, J. "An oncogene-tumor suppressor cascade drives metastatic prostate cancer by coordinately activating Ras and nuclear factor-B." Nature Medicine 16.3 (2010): 286-294.
description	2.	[Anon]. "KRAS oncogene cancers vulnerable to attack on genetic partners." Pharmacogenomics 10.12 (2009): 1891-1891.
description	3.	Bommi-Reddy, A. "Slaying RAS with a synthetic lethal weapon." Cell research 20.2 (2010): 119-121.
description	4.	Downward, J. "Finding the weakness in cancer." New England Journal of Medicine, The 361.9 (2009): 922-924.
description	5.	Turdi,, Subat, S. "Acute methamphetamine exposure inhibits cardiac contractile function." Toxicology Letters 189.2 (2009): 152-158.
description	6.	Dwyer, R. "Enacting multiple methamphetamines: The ontological politics of public discourse and consumer accounts of a drug and its effects." International Journal of Drug Policy 24.3 (2013): 203-211.
description	7.	Patrick Dawson, Patrick M. "Cardiovascular toxicity of novel psychoactive drugs: Lessons from the past." Progress in neuro-psychopharmacology & biological psychiatry 39.2 (2012): 244-252.
description	8.	Suda, K. "Biological and clinical significance of KRAS mutations in lung cancer: an oncogenic driver that contrasts with EGFR mutation." Cancer and Metastasis Reviews 29.1 (2010): 49-60.
description	9.	Azmi, A. "MDM2 inhibitor MI-319 in combination with cisplatin is an effective treatment for pancreatic cancer independent of p53 function." European journal of cancer 46.6 (2010): 1122-1131.
description	10.	[Anon]. "Cutting off a Tumor's Molecular Life Preserver." Cell 139.5 (2009): 835-835.
description	11.	Luo, J. "A Genome-wide RNAi Screen Identifies Multiple Synthetic Lethal Interactions with the Ras Oncogene." Cell 137.5 (2009): 835-848.
description	12.	Zhao, F. "Triptolide alters histone H3K9 and H3K27 methylation state and induces G0/G1 arrest and caspase-dependent apoptosis in multiple myeloma in vitro." Toxicology 267.1-3 (2010): 70-79.
description	13.	DeNicola, Gina M. "RAS in cellular transformation and senescence." European journal of cancer 45 Suppl 1.Suppl 1 (2009): 211-216.
description	14.	Singh, A. "Oncogenic K-ras "addiction" and synthetic lethality." Cell cycle 8.17 (2009): 2676-7.
description	15.	Yuan, W. "ANTI-APOPTOTIC EFFECT OF HEAT SHOCK PROTEIN 90 ON HYPOXIA-MEDIATED CARDIOMYOCYTE DAMAGE IS MEDIATED VIA THE PHOSPHATIDYLINOSITOL 3-KINASE/AKT PATHWAY." Clinical and experimental pharmacology & physiology 36.9 (2009): 899-903.
description	16.	Demark-Wahnefried, W. "A weighty matter--lifting after breast cancer." New England Journal of Medicine, The 361.7 (2009): 710-1.
description	17.	Griffin, Margaret L. "Measuring principal substance of abuse in comorbid patients for clinical research." Addictive Behaviors 34.10 (2009): 826-829.
description	18.	Strebhardt, K. "Targeting polo-like kinase 1 for cancer therapy." Nature reviews. Cancer 6.4 (2006): 321-330.
description	19.	Downward, J. "Targeting RAS and PI3K in lung cancer." Nature medicine 14.12 (2008): 1315-1316.
description	20.	Scholl, C. "Synthetic Lethal Interaction between Oncogenic KRAS Dependency and STK33 Suppression in Human Cancer Cells." Cell 137.5 (2009): 821-834.